Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Kimmie McLaurin"'
Publikováno v:
PLoS ONE, Vol 13, Iss 10, p e0205399 (2018)
OBJECTIVE:Respiratory syncytial virus (RSV) is a common pathogen during infancy, with the potential to cause serious disease and mortality in high-risk groups. The objective of this study was to characterize trends of RSV and bronchiolitis hospitaliz
Externí odkaz:
https://doaj.org/article/254d26ddb7044b55a5f7cd6658dfd47b
Autor:
Abigail Doucette, Xiaohui Jiang, Jon Fryzek, Jenna Coalson, Kimmie McLaurin, Christopher S Ambrose
Publikováno v:
PLoS ONE, Vol 11, Iss 4, p e0152208 (2016)
BACKGROUND:Respiratory syncytial virus (RSV) causes significant pediatric morbidity and is the most common cause of bronchiolitis. Bronchiolitis hospitalizations declined among US infants from 2000‒2009; however, rates in infants at high risk for R
Externí odkaz:
https://doaj.org/article/42a1b2304eee4f828d08b1cf59505d34
Autor:
Suvina Amin, Sara M Tolaney, M Janelle Cambron-Mellott, Kathleen Beusterien, Martine C Maculaitis, Emily Mulvihill, Reshma Shinde, Kimmie McLaurin
Publikováno v:
Future Oncology. 18:1927-1941
The goal of this study was to understand the preferences of patients and physicians for the benefits and risks associated with the treatment of advanced breast cancer that expresses normal amounts of the HER2 protein (termed as HER2 negative). Respon
Autor:
Daniel Simmons, Stephanie V. Blank, Adam C. ElNaggar, Benjamin Chastek, Scott H. Bunner, Kimmie McLaurin
Publikováno v:
Advances in Therapy. 39:2544-2561
Autor:
Rebecca L Stone, M Janelle Cambron-Mellott, Kathleen Beusterien, Martine C Maculaitis, Stephanie Ritz, Emily Mulvihill, Matthew Monberg, Elizabeth A Szamreta, Suvina Amin, Kimmie McLaurin
Publikováno v:
Future Oncology. 18:491-503
Plain language summary Maintenance therapy is a treatment option intended to keep ovarian cancer from coming back or getting worse for as long as possible after responding to chemotherapy. PARP inhibitors are a new type of maintenance therapy for ova
Autor:
Daniel, Simmons, Stephanie V, Blank, Adam C, ElNaggar, Benjamin, Chastek, Scott H, Bunner, Kimmie, McLaurin
Publikováno v:
Advances in therapy. 39(6)
Ovarian cancer (OC) is one of the leading causes of cancer mortality among women in the United States. With the approval of first-line maintenance therapies, patients with OC experienced prolonged first-line progression-free survival. While the liter
Autor:
John White, Daniel Simmons, Stephanie Blank, Adam ElNaggar, Jiefen Munley, Valery Walker, Sharanya Murali, Kimmie McLaurin
Publikováno v:
Gynecologic Oncology. 166:S192